Two Sigma Advisers’s Core Laboratories CLB Stock Holding History

Two Sigma Advisers’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9,900	Closed	-$275K	–	2648
2021 Q3	$275K	Buy	+9,900	New	+$301K	﹤0.01%	2145
2021 Q2	–	Sell	-13,700	Closed	-$394K	–	2476
2021 Q1	$394K	Buy	+13,700	New	+$468K	﹤0.01%	2113
2020 Q2	–	Sell	-167,900	Closed	-$1.74M	–	2500
2020 Q1	$1.74M	Buy	+167,900	New	+$4.7M	0.01%	1188
2019 Q1	–	Sell	-11,600	Closed	-$692K	–	2313
2018 Q4	$692K	Sell	11,600 -19,400	-63%	-$1.67M	﹤0.01%	1644
2018 Q3	$3.59M	Sell	31,000 -45,100	-59%	-$5.09M	0.01%	959
2018 Q2	$9.61M	Sell	76,100 -8,300	-10%	-$1.01M	0.03%	609
2018 Q1	$9.13M	Buy	84,400 +70,400	+503%	+$7.79M	0.02%	617
2017 Q4	$1.53M	Buy	14,000 +300	+2%	+$29.9K	﹤0.01%	1362
2017 Q3	$1.35M	Buy	13,700 +5,100	+59%	+$494K	﹤0.01%	1375
2017 Q2	$871K	Buy	+8,600	New	+$927K	﹤0.01%	1583

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

Two Sigma Advisers's CLB Position: Q4 2021 in Review

Two Sigma Advisers sold out of Core Laboratories (CLB) in Q4 2021, closing a stake of 9,900 shares — an estimated $275K sold.

Two Sigma Advisers first reported a position in CLB in Q2 2017 and held it in 10 quarters. The position peaked at $9.61M in Q2 2018. 173 funds tracked by Wall St. Rank hold CLB as of Q4 2021.

Two Sigma Advisers reported no remaining Core Laboratories position as of Q4 2021 after selling out during the quarter.
Two Sigma Advisers sold 9,900 Core Laboratories shares in Q4 2021, an estimated $275K.
Two Sigma Advisers first reported a position in Core Laboratories in Q2 2017 and held it in 10 quarters.
Two Sigma Advisers's Core Laboratories position peaked at $9.61M in Q2 2018.
173 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2021.

Based on Two Sigma Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.